|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$4,017
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
ECOG-ACRIN NCORP Research Base
|
5UG1CA189828-05
|
$21,554,621
|
|
WAGNER, LYNNE
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
The Center for Therapeutic Targeting of EWS-oncoproteins
|
1U54CA231637-01
|
$12,500,000
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
Breast Pre-Cancer Atlas Center
|
1U2CCA233254-01
|
$10,799,091
|
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
Precancer Atlas of Familial Adenomatous Polyposis
|
1U2CCA233311-01
|
$10,637,198
|
|
SNYDER, MICHAEL
|
STANFORD UNIVERSITY
|
|
Alliance NCORP Research Base
|
5UG1CA189823-05
|
$7,362,635
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)
|
1U2CCA233262-01
|
$6,918,530
|
|
SORGER, PETER
|
HARVARD MEDICAL SCHOOL
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
|
1U2CCA233238-01
|
$6,692,860
|
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
The Center for Synovial Sarcoma Biology and Therapeutics
|
1U54CA231638-01
|
$5,251,652
|
|
KADOCH, CIGALL
|
DANA-FARBER CANCER INST
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$48,955
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
|
5UM1CA154967-08
|
$4,864,165
|
|
CHEEVER, MARTIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childrens Oncology Group Pediatric Early Phase Clinical Trial Network
|
1UM1CA228823-01
|
$4,739,780
|
|
WEIGEL, BRENDA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
$43,057
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
|
1U01CA232491-01
|
$4,129,375
|
|
PACZESNY, SOPHIE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
|
1U01CA232486-01
|
$3,950,741
|
|
FRY, TERRY
|
UNIVERSITY OF COLORADO DENVER
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-31
|
$3,795,641
|
$75,913
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Kaiser Permanente NCI National Community Oncology Research Program NCORP
|
5UG1CA189821-05
|
$3,178,650
|
|
SUGA, JENNIFER
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Structural Cell Biology of DNA Repair Machines
|
5P01CA092584-18
|
$3,082,620
|
|
TAINER, JOHN
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
Heartland Cancer Research NCORP
|
5UG1CA189830-05
|
$2,990,806
|
|
FALLER, BRYAN
|
DECATUR MEMORIAL HOSPITAL
|
|
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
|
1U01CA232563-01
|
$2,931,750
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
|
5UM1CA186107-05
|
$2,867,003
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Accelerating Colorectal Cancer Screening and Follow-up through Implementation Science (ACCSIS) Program
|
1U24CA233218-01
|
$2,863,779
|
|
SUBRAMANIAN, SUJHA
|
RESEARCH TRIANGLE INSTITUTE
|
|
Translational Research in Cancer
|
5P30CA056036-18
|
$2,807,751
|
$28,078
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
|
5P01CA214278-02
|
$2,804,200
|
|
JUNE, CARL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Chile Gallbladder Cancer Study
|
ZIA CP010218 10540
|
$2,758,322
|
|
Koshiol, Jill
|
DCEG (NCI)
|
|
Cancer Research Consortium of West Michigan (CRCWM)
|
5UG1CA189860-05
|
$2,751,806
|
|
YOST, KATHLEEN
|
SPECTRUM HEALTH HOSPITALS
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$50,488
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
|
5P50CA097274-17
|
$2,500,000
|
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Mayo Clinic Breast Cancer SPORE
|
5P50CA116201-13
|
$2,471,635
|
|
GOETZ, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
|
5U19CA021239-38
|
$2,457,927
|
$245,793
|
HONG, THEODORE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The CSBC Research Center for Cancer Systems Immunology at MSKCC
|
5U54CA209975-03
|
$2,409,446
|
|
LESLIE, CHRISTINA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPORE in Prostate Cancer
|
5P50CA180995-04
|
$2,289,160
|
|
CATALONA, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$45,700
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
MD Anderson Gynecologic SPORE for Uterine Cancers
|
5P50CA098258-13
|
$2,268,692
|
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
SPORE in Cervical Cancer
|
5P50CA098252-15
|
$2,251,770
|
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
|
5P01CA138338-08
|
$2,222,937
|
|
HECHT, STEPHEN
|
UNIVERSITY OF MINNESOTA
|
|
Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma
|
1U01CA232490-01
|
$2,200,000
|
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression
|
5U54CA209971-03
|
$2,142,192
|
|
PLEVRITIS, SYLVIA
|
STANFORD UNIVERSITY
|
|
Centers for Cancer Systems Therapeutics (CaST)
|
5U54CA209997-03
|
$2,090,840
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Breast Cancer genetic study in African-ancestry populations
|
5R01CA202981-03
|
$2,090,789
|
|
ZHENG, WEI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Center on the Physics of Cancer Metabolism
|
5U54CA210184-03
|
$2,021,161
|
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
PHASE II SBIR CONTRACT - TOPIC 339 - MODULATION THERAPEUTICS - PD: DEEPA NARAYANAN - CO: ALEXIS HUDAK
|
261201700035C
|
$1,999,987
|
$1,999,987
|
UNKNOWN, UNKNOWN
|
MODULATION THERAPEUTICS, INC.
|
Total relevant funding to Eye for this search: $9,093,121
|